{
    "Trade/Device Name(s)": [
        "T-TAS 01 System with PL Chip",
        "Total Thrombus-formation Analysis (T-TAS) 01 System",
        "T-TAS 01 Instrument",
        "PL chip for T-TAS 01",
        "PL chip Reservoir Set for T-TAS 01",
        "BAPA tube for T-TAS 01"
    ],
    "Submitter Information": "Fujimori Kogyo Co., Ltd. (ZACROS)",
    "510(k) Number": "K191364",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060489"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JOZ"
    ],
    "Summary Letter Date": "February 14, 2020",
    "Summary Letter Received Date": "May 22, 2019",
    "Submission Date": "May 20, 2019",
    "Regulation Number(s)": [
        "21 CFR 864.5700"
    ],
    "Regulation Name(s)": [
        "Automated platelet aggregation system"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Platelet thrombus formation",
        "Primary hemostatic function"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "BAPA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "T-TAS 01 Instrument",
        "PL Chip for T-TAS 01"
    ],
    "Method(s)/Technology(ies)": [
        "Flow chamber assay",
        "Pressure sensing",
        "Collagen-coated microcapillary analysis"
    ],
    "Methodologies": [
        "Measurement of area under flow pressure curve (AUC)",
        "Platelet adhesion and aggregation assay"
    ],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Chip",
        "Tube",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for T-TAS 01 System with PL chip for assessment of platelet thrombus formation and primary hemostatic function using flow chamber pressure analysis",
    "Indications for Use Summary": "Intended for clinical laboratory analysis of platelet thrombus formation (primary hemostatic function) in adults (21+) with impaired primary hemostatic function or antiplatelet therapy history using BAPA-anticoagulated whole blood; includes collection, transport, and storage of specimens with BAPA tube",
    "fda_folder": "Hematology"
}